BackMonopar Therapeutics Overview

Monopar Therapeutics Operating Income

Operating Income for MNPR.

Quarterly Operating Income

$-5225253.00
↓ 99.84% YoY

As of Mar 31, 2026

Annual Operating Income (TTM)

$-4107688776.00
↓ 37.73% YoY

Trailing 12 months ending Mar 31, 2026

Average Operating Income (Comparison Companies)

Operating Income History

Operating Income Comparison

Annual Operating Income Growth Rate (%)

Annual Operating Income Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin